Sitemap

• Home
• About us
  • Pharmaceuticals
  • Vaccines
  • Consumer Healthcare
  • Corporate Executive Team
  • Governance
    • Board Committees
    • Other committees
    • Shareholders
    • Sarbanes-Oxley Act 2002
    • Compliance
  • Codes and standards
  • Our position on
  • Board of Directors
  • Our history
    • Innovative entrepreneurs: 1715 – 1891
    • Going global: 1892 – 1918
    • Building brands: 1919 – 1949
    • Creating the GSK of today: 1950 – 1999
    • GSK today: 2000 – present
    • GSK heritage archives
  • Key facts
• Products
  • Our prescription medicines
  • Our vaccines
  • Our consumer healthcare products
  • ViiV Healthcare
  • Stiefel dermatology
• Careers
  • Search jobs
  • COVID-19
  • Experienced professionals
    • Business operations
    • Engineering
    • Manufacturing and supply
    • Marketing and communications
    • Research and development
    • Sales
  • Physicians
  • Apprentices, students and graduates
    • School students - what next
    • Apprentice programmes
    • Work experience, placements and internships
    • Future Leaders graduate programme
    • Direct entry
  • PhDs and Postdocs
    • Esprit R&D Development Programme
    • Postdoctoral R&D
    • Postdoctoral Immunology Catalyst
    • GSK Vaccines Global PhD and Postdoc Programme
  • Meet our people
  • Our culture
  • Career benefits
  • Tips for applying
  • Warning against fraudulent internet recruitment activities
• Investors
  • About GSK
  • New GSK
  • Shareholder information
    • Dividend calculator (GBP)
    • Dividend calculator (USD)
    • Dividend calendar
    • Manage your shares
    • Annual General Meeting
    • General Meeting
    • Corporate sponsored nominee service
    • Asset Reunification – ProSearch
    • FAQs
    • Share scam alert
    • Annual Governance Meeting
    • Privacy Notice for Ordinary shareholders
  • Quarterly results
  • Speeches & presentations
  • Corporate reporting
    • Annual Report 2020
    • Corporate reporting archive
  • Share price analysis
    • GSK share price
    • Share price calculator (GBP)
    • Share price calculator (USD)
  • Financial calendar
  • Analyst consensus
  • Debt investors
  • Stock exchange announcements
    • London (RNS)
    • London (RNS) inside information
    • New York (SEC)
    • Sign up for announcements
  • Investors contact details
  • Corporate actions
    • Consumer Healthcare Joint Venture
    • Agreement to acquire TESARO
• Media
  • Press releases
  • Resource centre
    • Pharmaceuticals resources
    • Our response to COVID-19
    • COVID-19 prompts increased focus on self-care
    • Vaccine resources
  • Social media
  • RSS feeds
  • Image and video library
  • Media contact details
• Research and development
  • Our approach to R&D
  • Our pipeline
  • Research
    • How we research new medicines
    • How we research new vaccines
  • Development
    • How we develop new medicines
    • How we develop new vaccines
    • Vaccines
    • HIV
    • Infectious disease and global health
    • Oncology
    • Respiratory
    • Immuno-inflammation
  • Partnerships
    • Our areas of interest
    • Our approach to partnering
    • Supported studies
    • Business development
    • Academic collaborations
    • Venture funds
    • Contact us/submit an idea
  • Trials in people
    • GSK Study Register and patient level data
    • Clinical trial phases
    • Become a clinical research volunteer
    • Data transparency
    • Compassionate use (Expanded access)
  • Our use of animals
    • The 3Rs in medicine research
    • Use of non-human primates
    • Frequently asked questions
  • Consumer Healthcare research
  • R&D locations
• Responsibility
  • Improving health globally
    • Using our science for global health
    • Preparing for future disease threats
    • Pricing and access strategies
    • Prevention, awareness and infrastructure
    • “Pull” the Science: 2020 Antimicrobial Resistance Benchmark
  • Operating responsibly
    • Ethics and values
    • Patient safety and reliable supply
    • Research practices
    • Engaging with healthcare professionals
    • Sales force incentives programme
    • Public policy and patient advocacy
    • Human rights and modern slavery
  • Our people
    • Inclusion and diversity at GSK
    • Employee engagement
    • Health and wellbeing
    • Learning and development
  • Environment
    • Carbon
    • Water
    • Waste
    • Environmental stewardship
  • Charitable programmes and partnerships
    • UK charitable partnerships
    • Comic Relief partnership
    • Save the Children partnership
    • Smile Train partnership
  • Responsibility reports & data
    • Reporting archive and resources
    • Charitable grants
    • Trade association memberships
    • Patient organisation funding
• Contact us
  • Headquarters
  • Careers
  • Customers/patients
  • Funding requests
  • Partnerships
    • Business development
    • Academia
    • Neglected tropical diseases
  • Report a possible side effect
    • Pharmacovigilance, Medical Information and Product Quality Complaints - Data Privacy Notice
  • Worldwide
• Behind the science
  • Advancing the Next Generation of Immuno-Oncology
  • Outstanding People: Meet Sumitra
  • Outstanding People: Meet Graeme
  • Messenger ribonucleic acid (mRNA): Disrupting the field of vaccinology
  • Following the science of oxygen to discover solutions for anaemia
  • 40 years and counting: the fight against HIV
  • Outstanding People: Meet Sanjay
  • Combatting COVID-19: How do we tackle emerging variants?
  • Delivering potentially transformational medicines through R&D innovation in Oncology
  • Augmented reality and the changing face of consumer healthcare
  • Our focus on developing the next generation of antibiotics
  • The vaccines of tomorrow
  • Inclusive design: making our differences invisible
  • How do you test medicines in the real world?
  • Looking deeper into lupus
  • Unravelling the mysteries of the human genome with functional genomics
  • Immuno-Oncology: Integrating innovation into standard of care practice
  • Asthma management: it’s time to get personal
  • TB: uniting scientists to tackle one of the world’s biggest killers
  • Using vaccine science to combat antimicrobial resistance
  • Making the switch: how we’re improving access to proven medicines
  • The lung microbiome and the future management of respiratory disease
  • Revealing the beautiful complexity of the immune system
  • Why collaboration is essential to achieving new breakthroughs in vaccines
  • Tackling tomorrow’s health challenges today
  • From eucalyptus toothpaste to a brew for the flu: tailoring products to different tastes
  • We need more women in science to create the inclusive technologies of the future
  • STEM – inspiring tomorrow’s science and engineering superstars
  • Inside the Open Lab
  • Inside the vaccine factory of the future
  • Combining genetics and tech to double success rates for patients
  • Outstanding People: Meet Hangfei
  • Outstanding People: Meet Kevin
  • Getting ahead of infectious diseases with advanced technology
  • Outstanding People: Meet Umesh
  • Outstanding People: Meet Erin
  • 1.4 Million Reasons to Transform The Future of Women’s Cancer
• Terms of use
  • Overview
  • Global EULA for mobile apps using PII
  • Global EULA for mobile apps not using PII
• Business to business
  • Contract manufacturing
    • Active pharmaceutical ingredients
    • Steriles and clean liquids
    • Antibiotics
    • Solid dose
    • Platform technologies
    • Inhalation
    • BioPharm
    • Foams, liquids and topicals
  • Discovery and development consulting
    • Development insight
    • Technical approaches
    • Open innovation
• Accessibility
• Cookie policy
• GSK employees
• Privacy Notice
• GSK Instagram